Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01878617
Title A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors St. Jude Children's Research Hospital
Indications

medulloblastoma

Therapies

Vismodegib

Cisplatin + Cyclophosphamide + Vincristine Sulfate

Gemcitabine + Pemetrexed Disodium

Age Groups: adult | child
Covered Countries USA | CAN


No variant requirements are available.